Beijing Tiantan Biological Products (SHSE:600161) Ending Cash Position : ¥3,540 Mil (As of Sep. 2024)

View and export this data going back to 1998. Start your Free Trial

What is Beijing Tiantan Biological Products Ending Cash Position?

Beijing Tiantan Biological Products's Ending Cash Position for the quarter that ended in Sep. 2024 was ¥3,540 Mil.

Beijing Tiantan Biological Products's quarterly Ending Cash Position increased from Mar. 2024 (¥2,516 Mil) to Jun. 2024 (¥3,649 Mil) but then declined from Jun. 2024 (¥3,649 Mil) to Sep. 2024 (¥3,540 Mil).

Beijing Tiantan Biological Products's annual Ending Cash Position declined from Dec. 2021 (¥3,317 Mil) to Dec. 2022 (¥2,194 Mil) but then increased from Dec. 2022 (¥2,194 Mil) to Dec. 2023 (¥2,833 Mil).

Beijing Tiantan Biological Products Ending Cash Position Historical Data

The historical data trend for Beijing Tiantan Biological Products's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Tiantan Biological Products Ending Cash Position Chart

Beijing Tiantan Biological Products Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1,411.82

1,747.41

3,317.15

2,194.00

2,832.59

Beijing Tiantan Biological Products Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Ending Cash Position	Get a 7-Day Free Trial															3,348.18	2,832.59	2,516.18	3,649.29	3,540.50

Beijing Tiantan Biological Products Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Beijing Tiantan Biological Products's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2194.002	+	638.585
	=	2,833

Beijing Tiantan Biological Products's Ending Cash Position for the quarter that ended in Sep. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3649.288	+	-108.789
	=	3,540

Beijing Tiantan Biological Products Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Beijing Tiantan Biological Products's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Tiantan Biological Products Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Tiantan Biological Products Corp Ltd (SHSE:600161) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 6, Boxing 2nd Road, Room 521, Building 8, Beijing Economic and Technological Development Zone, Beijing, CHN, 100024

Website

https://www.tiantanbio.com

Beijing Tiantan Biological Products Corp Ltd uses healthy human plasma and specifically immunized human plasma as raw materials and adopts genetic recombination technology to develop and produce blood products and engage in the blood product business.

Executives

Zhang Yi	senior management
Ci Xiang	senior management
Fu Dao Xing	Directors, senior managers
Hu Li Gang	Director
Yang Hui Chuan	Director
Liu Ya Na	Directors, senior managers
He Yan Lin	Directors, senior managers
Wang Jian Ming	Supervisors
Wu Zhen Shan	senior management

Beijing Tiantan Biological Products Headlines

No Headlines